3 ms·
I recently listened to a podcast featuring Dr Matt McCarthy, who is an infection diseases physician and ethics professor and who authored the book Superbugs[1].
by ddeck 7y ago
I recently listened to a podcast featuring Dr Matt McCarthy, who is an infection diseases physician and ethics professor and who authored the book Superbugs[1].
He did a good job (to a layperson such as myself anyway) of explaining why big pharma don't have much incentive to develop new antibiotics, possible financial interventions that may makes sense, and the alternative treatments that are being developed.
I haven't read the book, but he's done quite a bit of press around it on podcasts, youtube etc. Definitely worth a listen to learn more about the topic.
[1] https://www.goodreads.com/en/book/show/42878826-superbugs https://www.goodreads.com/en/book/show/42878826-superbugs
- Dumblydorr 7y agoThe simple reason is pharma wants to develop chronic use drugs or cancer drugs, and why would they want to make antibiotics that are carefully rationed, if profits are lower? Seems to me, we may need a socialized, international effort, an ISS of antibiotic development.
- StreamBright 7y agoYep, I agree with him. Without the right incentives we are dead in the water.